Bank Of America Corp Rani Therapeutics Holdings, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 76,145 shares of RANI stock, worth $121,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,145

Previous 91,846 17.09%

Holding current value

$121,070

Previous $349,000 53.01%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.06 - $3.99 $32,344 - $62,646	-15,701 Reduced 17.09%	76,145 $164,000
Q2 2024 Aug 14, 2024	SELL	$3.13 - $7.85 $102,222 - $256,373	-32,659 Reduced 26.23%	91,846 $349,000
Q1 2024 May 15, 2024	BUY	$2.98 - $3.8 $30,533 - $38,934	10,246 Added 8.97%	124,505 $387,000
Q4 2023 Feb 14, 2024	SELL	$1.85 - $3.67 $107,357 - $212,973	-58,031 Reduced 33.68%	114,259 $379,000
Q2 2023 Aug 14, 2023	BUY	$3.92 - $5.58 $622,648 - $886,321	158,839 Added 1180.87%	172,290 $709,000
Q1 2023 May 12, 2023	BUY	$5.07 - $6.89 $48,763 - $66,268	9,618 Added 250.93%	13,451 $69,000
Q4 2022 Feb 10, 2023	BUY	$5.51 - $10.02 $6,116 - $11,122	1,110 Added 40.76%	3,833 $22,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $12.4 $4,756 - $7,167	578 Added 26.95%	2,723 $27,000
Q2 2022 Aug 12, 2022	SELL	$8.0 - $14.25 $8,080 - $14,392	-1,010 Reduced 32.01%	2,145 $22,000
Q1 2022 May 16, 2022	SELL	$12.21 - $23.14 $15,470 - $29,318	-1,267 Reduced 28.65%	3,155 $42,000
Q4 2021 Feb 08, 2022	BUY	$16.09 - $35.0 $47,545 - $103,425	2,955 Added 201.43%	4,422 $73,000
Q3 2021 Nov 15, 2021	BUY	$10.7 - $21.43 $15,696 - $31,437	1,467 New	1,467 $26,000

Others Institutions Holding RANI

# of Institutions

Shares Held

5.77M

Call Options Held

2.5K

Put Options Held

2.2K

View Full List

About Rani Therapeutics Holdings, Inc.

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $38.9M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

More about RANI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Rani Therapeutics Holdings, Inc. Transaction History